Otsuka files for tolvaptan in liver cirrhosis patients in Japan
This article was originally published in Scrip
Executive Summary
Otsuka Pharmaceutical has filed for the approval in Japan of tolvaptan for the additional indication of fluid retention associated with cirrhosis of the liver.